4.2 Article

ANCA Status or Clinical Phenotype - What Counts More?

Related references

Note: Only part of the references are listed.
Article Rheumatology

Temporal Arteritis Revealing Antineutrophil Cytoplasmic Antibody-Associated Vasculitides: A Case-Control Study

Laure Delaval et al.

Summary: TA-AAV can present with atypical symptoms of GCA, emphasizing the importance of ANCAs testing during diagnosis. Compared to classic GCA, patients with TA-AAV are typically younger, more frequently male, and exhibit more atypical manifestations with higher CRP levels. There is a significant difference in the risk of treatment failure among different types of patients.

ARTHRITIS & RHEUMATOLOGY (2021)

Article Urology & Nephrology

Slowly progressive anti-neutrophil cytoplasmic antibody-associated renal vasculitis: clinico-pathological characterization and outcome

Giorgio Trivioli et al.

Summary: AAV can present with slow renal disease progression; this subset is characterized by advanced age at diagnosis, positive MPO-ANCA, subclinical interstitial lung lesions, and chronic damage at kidney biopsy. Partial renal recovery may occur following immunosuppression.

CLINICAL KIDNEY JOURNAL (2021)

Review Immunology

The value of anti-neutrophil cytoplasmic antibodies (ANCA) testing for the diagnosis of ANCA-associated vasculitis, a systematic review and meta-analysis

Niels A. D. Guchelaar et al.

Summary: Testing for ANCA is crucial in diagnosing AAV, with immunoassays showing high sensitivity for PR3 and MPO antibodies. Furthermore, the specificity for c-ANCA tested by IIF is also high. This supports the recommendation to prioritize immunoassays for primary anti-PR3 and anti-MPO screening in the diagnostic workup of AAV, without the need for IIF ANCA testing.

AUTOIMMUNITY REVIEWS (2021)

Article Medicine, General & Internal

Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis

Michael Walsh et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Rheumatology

Comorbidities in ANCA-associated vasculitis

Andreas Kronbichler et al.

RHEUMATOLOGY (2020)

Article Medicine, General & Internal

Association of Cigarette Smoking With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis

Greg McDermott et al.

JAMA INTERNAL MEDICINE (2020)

Article Rheumatology

Cutaneous Manifestations of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis

Robert G. Micheletti et al.

ARTHRITIS & RHEUMATOLOGY (2020)

Review Immunology

Animal Models of ANCA Associated Vasculitis

Lani Shochet et al.

FRONTIERS IN IMMUNOLOGY (2020)

Article Immunology

THE alternative complement pathway in ANCA-associated vasculitis: further evidence and a meta-analysis

S. Moiseev et al.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2020)

Article Urology & Nephrology

Developments in the Histopathological Classification of ANCA-Associated Glomerulonephritis

Emma E. van Daalen et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)

Review Immunology

2020 international consensus on ANCA testing beyond systemic vasculitis

Sergey Moiseev et al.

AUTOIMMUNITY REVIEWS (2020)

Article Rheumatology

Clinical Profile of Levamisole-Adulterated Cocaine-Induced Vasculitis/Vasculopathy A 30-Case Series

Carlos Horacio Munoz-Vahos et al.

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2019)

Article Medicine, General & Internal

Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease

Oliver Distler et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Hematology

Statin Therapy to Revert Hypercoagulability and Prevent Venous Thromboembolism: A Narrative Review

Fernanda A. Orsi et al.

SEMINARS IN THROMBOSIS AND HEMOSTASIS (2019)

Article Urology & Nephrology

Development and validation of a renal risk score in ANCA-associated glomerulonephritis

Silke R. Brix et al.

KIDNEY INTERNATIONAL (2018)

Article Urology & Nephrology

Patient Outcomes in Renal-Limited Antineutrophil Cytoplasmic Antibody Vasculitis With Inactive Histology

Tessa K. Novick et al.

KIDNEY INTERNATIONAL REPORTS (2018)

Article Urology & Nephrology

Predictors of Renal Outcomes in Sclerotic Class Anti-Neutrophil Cytoplasmic Antibody Glomerulonephritis

Steven Menez et al.

AMERICAN JOURNAL OF NEPHROLOGY (2018)

Review Critical Care Medicine

Pathogenesis of ANCA-Associated Pulmonary Vasculitis

Marco A. Alba et al.

SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2018)

Article Health Care Sciences & Services

Management of cardiovascular risk factors in patients with ANCA-associated vasculitis

Carsten Paul Bramlage et al.

JOURNAL OF EVALUATION IN CLINICAL PRACTICE (2017)

Article Urology & Nephrology

Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis

David R. W. Jayne et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)

Editorial Material Transplantation

Vasculitis-when can biopsy be avoided?

David Jayne

NEPHROLOGY DIALYSIS TRANSPLANTATION (2017)

Review Immunology

Interstital lung disease in ANCA vasculitis

Marco A. Alba et al.

AUTOIMMUNITY REVIEWS (2017)

Review Rheumatology

ANCA-associated vasculitis - clinical utility of using ANCA specificity to classify patients

Divi Cornec et al.

NATURE REVIEWS RHEUMATOLOGY (2016)

Article Medicine, General & Internal

Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management

Matthieu Groh et al.

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2015)

Letter Rheumatology

Venous thromboembolic events in systemic vasculitis

Pavel Novikov et al.

ANNALS OF THE RHEUMATIC DISEASES (2015)

Article Urology & Nephrology

ANCA as a Predictor of Relapse: Useful in Patients with Renal Involvement But Not in Patients with Nonrenal Disease

Michael J. Kemna et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)

Article Rheumatology

2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides

J. C. Jennette et al.

ARTHRITIS AND RHEUMATISM (2013)

Review Urology & Nephrology

ACR/EULAR-endorsed study to develop Diagnostic and Classification Criteria for Vasculitis (DCVAS)

Anthea Craven et al.

CLINICAL AND EXPERIMENTAL NEPHROLOGY (2013)

Article Rheumatology

Proteinase-3 Antineutrophil Cytoplasm Antibody Positivity in Patients Without Primary Systemic Vasculitis

Stephen Paul McAdoo et al.

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2012)

Article Medicine, General & Internal

Genetically Distinct Subsets within ANCA-Associated Vasculitis

Paul A. Lyons et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Article Rheumatology

Long-term patient survival in ANCA-associated vasculitis

Oliver Flossmann et al.

ANNALS OF THE RHEUMATIC DISEASES (2011)

Article Urology & Nephrology

Histopathologic Classification of ANCA-Associated Glomerulonephritis

Annelies E. Berden et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)

Article Medicine, General & Internal

Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis.

John H. Stone et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Article Medicine, General & Internal

Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis.

Rachel B. Jones et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Article Urology & Nephrology

Antibodies with Dual Reactivity to Plasminogen and Complementary PR3 in PR3-ANCA Vasculitis

David J. Bautz et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)

Article Medicine, General & Internal

ANCA are detectable in nearly all patients with active severe Wegener's granulomatosis

Javier D. Finkielman et al.

AMERICAN JOURNAL OF MEDICINE (2007)

Article Urology & Nephrology

Outcome of ANCA-associated renal vasculitis: A 5-year retrospective study

AD Booth et al.

AMERICAN JOURNAL OF KIDNEY DISEASES (2003)

Review Urology & Nephrology

Antiproteinase 3-and antimyeloperoxidase-associated vasculitis

CFM Franssen et al.

KIDNEY INTERNATIONAL (2000)